Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread

A. David Soleymani; Noah Scheinfeld; Katherine Vasil; Mark A. Bechtel

doi:10.1016/j.jaad.2007.08.041

Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread

A. David Soleymani
, Noah Scheinfeld
, Katherine Vasil
, Mark A. Bechtel

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Abstract

Basal cell carcinoma (BCC), the most common human malignancy, metastasizes in 0.0028% to 0.5% of cases, usually to the lymph nodes, lungs, bones, and skin. After metastatic spread of BCC, survival averages 1 to 2 years. Chemotherapy, radiotherapy, and surgery are treatment options. We describe metastatic basal cell carcinoma to the skin presenting with unilateral upper extremity edema.

Original language	English
Pages (from-to)	S1-S3
Journal	Journal of the American Academy of Dermatology
Volume	59
Issue number	2 SUPPL.
DOIs	https://doi.org/10.1016/j.jaad.2007.08.041
State	Published - Aug 2008

Access to Document

10.1016/j.jaad.2007.08.041

Cite this

@article{ad66e2dde79a4ae2b96b34876b14ecde,

title = "Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread",

abstract = "Basal cell carcinoma (BCC), the most common human malignancy, metastasizes in 0.0028\% to 0.5\% of cases, usually to the lymph nodes, lungs, bones, and skin. After metastatic spread of BCC, survival averages 1 to 2 years. Chemotherapy, radiotherapy, and surgery are treatment options. We describe metastatic basal cell carcinoma to the skin presenting with unilateral upper extremity edema.",

author = "Soleymani, \{A. David\} and Noah Scheinfeld and Katherine Vasil and Bechtel, \{Mark A.\}",

year = "2008",

month = aug,

doi = "10.1016/j.jaad.2007.08.041",

language = "English",

volume = "59",

pages = "S1--S3",

journal = "Journal of the American Academy of Dermatology",

issn = "0190-9622",

number = "2 SUPPL.",

}

TY - JOUR

T1 - Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread

AU - Soleymani, A. David

AU - Scheinfeld, Noah

AU - Vasil, Katherine

AU - Bechtel, Mark A.

PY - 2008/8

Y1 - 2008/8

N2 - Basal cell carcinoma (BCC), the most common human malignancy, metastasizes in 0.0028% to 0.5% of cases, usually to the lymph nodes, lungs, bones, and skin. After metastatic spread of BCC, survival averages 1 to 2 years. Chemotherapy, radiotherapy, and surgery are treatment options. We describe metastatic basal cell carcinoma to the skin presenting with unilateral upper extremity edema.

AB - Basal cell carcinoma (BCC), the most common human malignancy, metastasizes in 0.0028% to 0.5% of cases, usually to the lymph nodes, lungs, bones, and skin. After metastatic spread of BCC, survival averages 1 to 2 years. Chemotherapy, radiotherapy, and surgery are treatment options. We describe metastatic basal cell carcinoma to the skin presenting with unilateral upper extremity edema.

UR - https://www.scopus.com/pages/publications/46749088648

U2 - 10.1016/j.jaad.2007.08.041

DO - 10.1016/j.jaad.2007.08.041

M3 - Article

C2 - 18625368

AN - SCOPUS:46749088648

SN - 0190-9622

VL - 59

SP - S1-S3

JO - Journal of the American Academy of Dermatology

JF - Journal of the American Academy of Dermatology

IS - 2 SUPPL.

ER -

Metastatic basal cell carcinoma presenting with unilateral upper extremity edema and lymphatic spread

Abstract

Access to Document

Other files and links

Fingerprint

Cite this